this post was submitted on 27 Jun 2025
6 points (100.0% liked)

worldnews

2511 readers
19 users here now

Welcome! This community is constantly upgrading and is a current work in progress. Please stay tuned.

/c/[email protected] strives for high-quality standards on the latest world events.

The basis of these standards comes from the MBFC, which uses an aggregate of methodologies, including the IFCN and World Freedom Indices, to rate the Bias and Factual Reporting of News.

These are non-profit organisations with full transparency of their funding and structure. Likewise, this community is also transparent – Please feel free to question its staff and the overall content of this community.


Does your post fit the standards? Check this thread!



Rules:


Disallowed submissions

Commenters will receive one public warning with only one strike if violating any of the following rules:

Thank you.

todo list:

founded 2 years ago
MODERATORS
 

Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, the Bureau of Investigative Journalism (TBIJ) can reveal.

The drugs in question form the backbone of treatment plans for numerous common cancers including breast, ovarian and leukemia. Some drugs contained so little of their key ingredient that pharmacists said giving them to patients would be as good as doing nothing. Other drugs, containing too much active ingredient, put patients at risk of severe organ damage or even death. “Both scenarios are horrendous,” said one pharmacist. “It’s heartbreaking.”

Doctors from multiple countries told TBIJ of the drugs in question not working as expected, leaving patients suddenly unresponsive to treatment. Other patients suffered side effects so toxic that they could no longer tolerate the medicine.

The variance found in the levels of active ingredient was alarming. In some cases, pills from the same blister pack contained different amounts.

These findings expose huge holes in the global safety nets intended to stop manufacturers cutting corners to boost profits, and to protect patients from bad drugs. All the while, patients and governments with stretched resources are paying the price for drugs that don’t work.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here